Senior’s Health – Cancer Prevention and Magnesium

With one in two men and one in three women developing cancer in their lifetime, it’s important to cover the relationship of cancer to magnesium deficiency.

Research and experimental data suggest that adequate magnesium might protect against initiation of precancerous cellular changes. However, although increased longevity in magnesium-rich geographic areas is clearly correlated with lower heart disease mortality,(1-3,4,5-13) its correlation with cancer prevalence is inconsistent.(14,15-20,21-35) The risk of most cancers increases with aging, and with length of exposure to agents with cancerous potential.

Despite provocative findings that suggest that magnesium deficiency might be implicated in aspects of the development and treatment of abnormal cell proliferation potentially leading to cancer, there are many unknowns. Investigation of these questions might lead to means to prevent certain types of cancers. Whether higher magnesium intakes might be protective against the processes that lead to tumor formation in humans as it is in some animal models deserves study.

For a complete article on the relationship between cancer and magnesium by Dr. Midlred Seelig seehttp://www.mgwater.com/cancer.shtml 

References

1. Schroeder, H.A. Relations between hardness of water and death rates from certain chronic and degenerative disease in the United States. J. Chron. Dis. 1960; 12:586-591.

2. Anderson, T.W., Neri, L., Schreiber, G.B., Talbot, F., Zdrowjewski, A. Ischemic heart disease, water hardness and myocardial magnesium. Can. Med. Assoc. J. 1975; 113:199-203.

3.Marier, J.R. Cardioprotective contribution of hard water to magnesium intake. Rev. Can. Biol. 1978; 37:115-125.

4. Seelig, M.S. Magnesium Deficiency in the Pathogenesis of Disease. Early Roots of Cardiovascular, Skeletal, and Renal Abnormalities. Ed. L.V. Avioli, Publ. Plenum Med. Book Co., New York, N.Y., 1980.

5. Seelig, M.S., Heggtveit, H.A. Magnesium interrelationships in ischemic heart disease. Am. J. Clin. Nutr. 1974; 27:59-79.

6. Seelig, M.S. Magnesium requirements in human nutrition. (from 3rd Intl. Mg Sympos., 1981, Baden-Baden, Germany) Magnesium Bull.1981; 3(1a):26-47.

7. Seelig, M.S. Nutritional status and requirements of magnesium, with consideration of individual differences and prevention of cardiovascular disease. (from 2nd Europ. Congr. on Mg, Stockholm, Sweden, 1986), Magnesium Bull. 1986; 8:170-185.

8. Seelig, M.S. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations – magnesium and chloride loss in refractory potassium repletion. Am. J. Cardiol. 1989; 63:4G-21G.

9. Altura, B.M., Altura, B.T. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Clinical aspects. Magnesium 1985; 4:226-244.

10. Anderson, T.W., LeRiche, W.H. Sudden death from ischemic heart disease in Ontario and its correlation with water hardness and other factors. Can. Med. Assoc. J. 1971; 105:155-160.

11. Anderson, T.W., Leriche, W.H., Hewitt, D., Neri, L.C.: Magnesium, water hardness, and heart disease. In Magnesium in Health and Disease, (from 2nd Intl. Mg Sympos., Montreal, Canada, 1976), Eds., M. Cantin, M.S. Seelig, Publ. Spectrum Press, NY, 1980; 565-571.

12. Neri, L.C., Johansen, H.L., Hewitt, D., Marier, J., Langner, N. Magnesium and certain other elements and cardiovascular disease. Sci. Tot. Environm. 1985; 42:49-75.

13. Karppannen, H. Epidemiologic evidence for considering magnesium deficiency as a risk factor for cardiovascular diseases. Magnesium Bull. 1990; 12:80-86.

14. Seelig, M.S. Magnesium (and trace substance) deficiencies in the pathogenesis of cancer. Biol. Tr. Elem. Res. 1979; 1:273-297.

15. Collery, P., Anghileri, L.J., Coudoux, P., Durlach, J. (Magnesium and cancer: Clinical data.) Magnesium Bull. 1981; 3:11-20.

16. Bazikian, K.L. The significance of magnesium salts in oncology. Proc of First Intl Mg Sympos, Vittel, France, Ed. J. Durlach (private printer) 1971; 593-606.

17. Aleksandrowicz, J. Natural environment and health. In Protection of Man’s Natural Environment Polish Sci. Publ. 1973; 518-528.

18. Aleksandrowicz, J., Blicharski, J., Dzigowska, A., Lisiewicz, J. Leuko- and oncogenesis in the light of studies on metabolism of magnesium and its turnover in biocenosis. Acta Med. Pol. 1970; 11:289-302. (abstr: Blood 1971; 37:245)

19. Aleksandrowicz, J. (Mycotoxins, bioelements, and perspectives in prophylaxis in the ecology of leukemia). Rev. Esp. Encologia 1975; 22:311-333.

20. Aleksandrowicz,J., Skotnicki, A.B., (transl by E. Nowak) Leukemia Ecology. Ecological Prophylaxis of Leukemia. (Avail from U.S. Dept. Commerce, Natl. Techn. Inform. Serv. Springfield VA 22161) 1982.

21. Haury, V.G. Variations in serum magnesium in health and disease: A review. J. Lab. Clin. Med. 1942; 27:1361-1375.

22. Delbet, P. Presse Med. 1928; 36:1473. (cited by Haury #58)

23. Delbet, P., Robinet, L. Terrains magnesiens et cancer. Bull. Acad. Med. Paris 1932; 111:415. (cited by Haury #58)

24. Bablet, J., Bader, H. Magnesium and cancer in Indochina. Bull. Assoc. Franc.l’Etude de Cancer 1932; 21:570. (cited by Haury #58)

25. Schrupf-Peirron, P. (Causes of rarity of cancer in Egypt). Bull. Acad. Med. Paris 1931; 105:818, 106:235. (cited by Haury, #58)

26. Marchi, C. Carenza di cloruro di magnesio e maggior frequenza di canril not a preventiva. Seritta Biol. 1930, 4:295. (cited by Haury, #58)

27. Heinemann, H. Hippokrates 1953; 24:744. (cited by Bazikian, #14)

28. Neiper, H.A. Med. Welt 1953; 154:272, 1282. (cited by #14)

29. Akemtsev, V. Pochvovedie 1957; 7:91, 1957 (cited by Bazikian, #14)

30. Akemtsev, V., Milin, Z., Smolianionov, J. Moskva 1966; 45:1966. (cited by Bazikian, #14)

31. Balasanian, S. Geokhimia 1959; 3:226, 1959. (cited by Bazikian #14)

32. Miron, W., Sobaniec-Lotowska, M., Sulkowski, S. [Malignant neoplasms in autopsy specimens and the magnesium level in the soil of the communities of Grodek and Tykocin.] Wiad. Lek. 1989; 42:1033-1074.

33. Armstrong, R.W. Is there a particular kind of soil or geologic environment that predisposes to cancer? Ann. N.Y. Acad. Sci. 1972; 199:239-248.

34. World Health Organization Report: Prevention of cancer Tech Rep Ser 276, 1964) & Intl Agency on Cancer, Lyons 1977 (cited by Aleksandrowicz, #18)

35. Mason, T.J., MacKay, F.W., Blot, W.J., Fraumeni, J.F. Jr. Atlas of Cancer Mortality for U.S. Counties: 1950-1969. 1975; DHEW Publ #NIH 75-780.